Sequential PVP-I and FV

ConditionDental Caries
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-24
SponsorAdvantage Silver Dental Arrest, LLC

About this trial

This prospective cohort study in children will determine if: topical povidone iodine 10% followed by topical fluoride varnish is superior to placebo iodine followed two different varnishes alone to prevent tooth decay (dental caries).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Children 6-24 months of age at enrollment. To be eligible a child will have at least 1 erupted tooth that is either sound or has only a d1 (white spot) lesion.

Disqualifiers

Previous treatment with fluoride varnish

Known allergy to iodine

Diagnosis of thyroid disease

Chronic, prophylactic use of antibiotics

Trial population

Children served by two health centers in Puno serving the "Control de Crecimiento y Desarrollo (CRED)" program and the Faculty of Health Sciences, Professional School of Dentistry, National University of the Altiplano, Puno, Peru.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • fluoride varnish, 2.5%

    Device

    sodium fluoride, 2.5%

  • topical fluoride, 2.1%

    Device

    sodium fluoride, 2.1%

  • Povidone Iodine Topical

    Drug

    Povidone Iodine, 10%

Treatment groups

393 Participants
are divided into 3 treatment groups
Group A: Povi+Fluorimax2 interventions
Group B: Placebo+Fluorimax1 intervention
Group C: Placebo+ClinPro1 intervention

Trial outcomes

Primary outcomes

1

Surface level caries

d2-4mfs

Time frame
24 months

Secondary outcomes

1

Presence/Absence of dental caries lesions

d2-4mfs\>0

Time frame
24 months

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Advantage Silver Dental Arrest, LLC

Lead sponsor

Universidad Nacional del Altiplano de Puno

Collaborator

University of Washington

Collaborator

This trial is not recruiting at the moment. You can still explore other options: